Literature DB >> 316686

Inactivation of beta-lactam antibiotics by Legionella pneumophila.

K P Fu, H C Neu.   

Abstract

Beta-lactam-inactivating activity has been found in all sero-groups of Legionella pneumophila. The beta-lactamase activity could be detected in intact cells and released by ethylenediaminetetraacetic acid treatment, indicating that it is located in the periplasmic space. The enzyme acted primarily as a cephalosporinase hydrolyzing cefamandole, cephalothin, cephaloridine, and also penicillin G and ampicillin. Cefoxitin and cefuroxime were not hydrolyzed. Clavulanic acid and CP-45,899, beta-lactamase inhibitors, prevented the hydrolysis of cephalosporins and penicillins. The beta-lactamase activity appears to be different from that found in Enterobacteriaceae and Pseudomonas.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316686      PMCID: PMC352905          DOI: 10.1128/AAC.16.5.561

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

Review 1.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

2.  Comparative inhibition beta-lactamases by novel beta-lactam compounds.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

3.  Clavulanic acid, a novel inhibitor of beta-lactamases.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

4.  In vitro activity of antimicrobial agents on Legionnaires disease bacterium.

Authors:  C Thornsberry; C N Baker; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

5.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

6.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

7.  Studies on gonococcus infection. XI. Comparison of in vivo and vitro association of Neisseria gonorrhoeae with human neutrophils.

Authors:  G King; J F James; J Swanson
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

  7 in total
  17 in total

1.  Bactericidal effects of ticarcillin-clavulanic acid against Legionella pneumophila pneumonia in immunocompromised weanling rats.

Authors:  G M Smith; K H Abbott; M J Wilkinson; A S Beale; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Microbiota regulates immune defense against respiratory tract influenza A virus infection.

Authors:  Takeshi Ichinohe; Iris K Pang; Yosuke Kumamoto; David R Peaper; John H Ho; Thomas S Murray; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

3.  Isolation of a gene encoding a novel spectinomycin phosphotransferase from Legionella pneumophila.

Authors:  T M Suter; V K Viswanathan; N P Cianciotto
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

4.  Extracellular enzymes of Legionella pneumophila.

Authors:  T C Thorpe; R D Miller
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

5.  Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila.

Authors:  D J Pohlod; L D Saravolatz; E L Quinn; M M Somerville
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

Review 6.  Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

7.  What do beta-lactamases mean for clinical efficacy?

Authors:  H C Neu
Journal:  Infection       Date:  1983       Impact factor: 3.553

8.  Characterization of the beta-lactamases of six species of Legionella.

Authors:  R Marre; A A Medeiros; A W Pasculle
Journal:  J Bacteriol       Date:  1982-07       Impact factor: 3.490

9.  Disk diffusion antimicrobial susceptibility testing of members of the family Legionellaceae including erythromycin-resistant variants of Legionella micdadei.

Authors:  J N Dowling; D A McDevitt; A W Pasculle
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

10.  Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents.

Authors:  A W Pasculle; J N Dowling; R S Weyant; J M Sniffen; L G Cordes; G M Gorman; J C Feeley
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.